Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) EPS (Basic) : HK$0.11 (TTM As of Mar. 2024)

View and export this data going back to 2002. Start your Free Trial

What is Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EPS (Basic)?

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's basic earnings per share (Basic EPS) for the three months ended in Mar. 2024 was HK$0.00. Its basic earnings per share (Basic EPS) for the trailing twelve months (TTM) ended in Mar. 2024 was HK$0.11.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EPS (Diluted) for the three months ended in Mar. 2024 was HK$0.00. Its EPS (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was HK$0.11.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EPS without NRI for the three months ended in Mar. 2024 was HK$0.01. Its EPS without NRIearnings per share without non-recurring items for the trailing twelve months (TTM) ended in Mar. 2024 was 0.11.

During the past 12 months, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's average EPS without NRIGrowth Rate was -54.30% per year. During the past 3 years, the average EPS without NRI Growth Rate was -20.60% per year. During the past 5 years, the average EPS without NRI Growth Rate was -11.60% per year. During the past 10 years, the average EPS without NRI Growth Rate was -1.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's highest 3-Year average EPS without NRI Growth Rate was 43.30% per year. The lowest was -20.60% per year. And the median was 11.75% per year.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EPS (Basic) Historical Data

The historical data trend for Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EPS (Basic) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EPS (Basic) Chart

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EPS (Basic)

Get a 7-Day Free Trial

0.28

0.20

0.26

0.15

0.12

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Quarterly Data
	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EPS (Basic)	Get a 7-Day Free Trial															0.01	0.07	0.02	0.02	-

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EPS (Basic) Calculation

EPS (Basic) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Basic earnings per share (EPS) do not factor in the dilutive effects on convertible securities.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Basic EPS for the fiscal year that ended in Dec. 2023 is calculated as

Basic EPS (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(118.814	-	0)	/	1034.048
	=	0.11

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's Basic EPS for the quarter that ended in Mar. 2024 is calculated as

Basic EPS (Q: Mar. 2024 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Basic Average)
	=	(2.55	-	0)	/	1043.000
	=	0.00

EPS (Basic) for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was HK$0.11

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) EPS (Basic) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co EPS (Basic) Related Terms

Thank you for viewing the detailed overview of Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co's EPS (Basic) provided by GuruFocus.com. Please click on the following links to see related term pages.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd (HKSE:01349) » Definitions » EPS (Basic)

Comparable Companies

Traded in Other Exchanges

688505:China

Address

No. 308, Cai Lun Road, Zhangjiang Hi-Tech Park, Pudong, Shanghai, CHN, 201210

Website

http://www.fd-zj.com

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co Ltd is engaged in the research, development, manufacturing, and sale of biopharmaceutical products. Its product portfolio includes ALA (Aminolevulinic acid Hydrochloride); FuMeiDa and Libord. Geographically, it derives revenue from Mainland China.

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co (HKSE:01349) Headlines

No Headlines